Your browser doesn't support javascript.
loading
Case Report: The Role of Molecular Analysis of the MUTYH Gene in Asymptomatic Individuals.
Fabisíková, Katarína; Hamidová, Olívia; Behulová, Regína Lohajová; Závodná, Katarína; Priscáková, Petra; Repiská, Vanda.
Afiliação
  • Fabisíková K; Faculty of Medicine, Institute of Medical Biology, Genetics and Clinical Genetics, Comenius University, Bratislava, Slovakia.
  • Hamidová O; Department of Clinical Genetics, St. Elizabeth Cancer Institute, Bratislava, Slovakia.
  • Behulová RL; Department of Clinical Genetics, St. Elizabeth Cancer Institute, Bratislava, Slovakia.
  • Závodná K; Department of Clinical Genetics, St. Elizabeth Cancer Institute, Bratislava, Slovakia.
  • Priscáková P; Faculty of Medicine, Institute of Medical Biology, Genetics and Clinical Genetics, Comenius University, Bratislava, Slovakia.
  • Repiská V; Faculty of Medicine, Institute of Medical Biology, Genetics and Clinical Genetics, Comenius University, Bratislava, Slovakia.
Front Genet ; 11: 590486, 2020.
Article em En | MEDLINE | ID: mdl-33384714
ABSTRACT
MUTYH-associated polyposis (MAP) is a rare hereditary condition caused by the biallelic mutation in the MUTYH gene encoding MUTYH glycosylase. This enzyme is a key member of the base excision repair (BER) pathway responsible for the repair of DNA lesions formed by reactive oxygen species (ROS). We report two cases of MAP. In case 1, a 67-year-old woman who presented with a personal history of colorectal and endometrial cancer and a family history of cancer syndromes underwent multigene panel testing that revealed a germline homozygous (biallelic) pathogenic variant c.1187G > A (p.Gly396Asp) in the MUTYH gene. Subsequent sequencing analysis performed in the offspring of the proband identified all three asymptomatic offspring as carriers of this pathogenic variant. In case 2, a 40-year-old woman with a strong family history of colorectal cancer [the proband's sister was a carrier of the pathogenic variant c.536A > G (p.Tyr179Cys) of the MUTYH gene] and renal cancer underwent sequencing analysis of the MUTYH gene. The pathogenic heterozygous (monoallelic) variant c.536A > G (p.Tyr179Cys) of the MUTYH gene was identified in the proband. We found another pathogenic variant of the MUTYH gene-heterozygous (monoallelic) mutation c.1187G > A (p.Gly396Asp) in the genome of the proband's husband. Molecular analysis of their offspring revealed that they are compound heterozygotes for MUTYH pathogenic variants c.536A > G (p.Tyr179Cys)/c.1187G > A (p.Gly396Asp). This paper shows the importance of genetic testing of asymptomatic relatives of the proband to ensure an early surveillance and management of individuals positive for pathogenic variant (s) in the MUTYH gene.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Genet Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Eslováquia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Genet Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Eslováquia